Proteomic genotyping for individual human identification: Inferring SNPs in the absence of DNA evidence
- PMID: 41014682
- DOI: 10.1016/j.forsciint.2025.112664
Proteomic genotyping for individual human identification: Inferring SNPs in the absence of DNA evidence
Abstract
Proteins exhibit genetic variation due to differences in the amino acid sequence of proteins within and between populations. Amongst individuals this variation is most commonly in the form of single amino acid polymorphisms (SAPs) resulting from the translation of a non-synonymous single nucleotide polymorphism (SNP). The identification of SAPs can be used to infer the presence of corresponding SNP allele genotypes. When viable DNA is absent, proteomic genotyping may be used to associate biological evidence with an individual, similarly to other genetic markers of identification. As with DNA-based genotypes, this information can achieve potentially high levels of discriminating power and provide investigative leads including ancestry or biogeographic background. In forensic investigation the use of SNPs for individual identification continues to be explored at the nucleic acid level. However, in circumstances where DNA is not recovered, poorly recovered, or recovered as a complex mixture, alternative or complementary approaches for obtaining molecular markers of genetic variation would be valuable to investigators. Variations in the amino acid sequence of chemically abundant and stable proteins provides this opportunity. Using a proteomics approach, it's possible to determine the presence of SNPs in an individual's genome by revealing SAPs in the amino acid sequence of polypeptides. Ongoing research aims to use this information to bridge a gap in forensic intelligence gathering by applying emerging proteomics technologies to the analysis of biological matrices, most notably hair, an underutilised type of biological evidence.
Keywords: Forensic proteomics; Genetically variant peptides; Mass spectrometry; Proteomic genotyping; Single nucleotide polymorphisms.
Copyright © 2025. Published by Elsevier B.V.
Conflict of interest statement
Declaration of Competing Interest The corresponding author, GJP, has a patent based on the use of genetically variant peptides for human identification (US 8,877,455 B2, Australian Patent 2011229918, Canadian Patent CA 2794248, and European Patent EP11759843.3). The patent is owned by Parker Proteomics LLC. Protein-Based Identification Technologies LLC (PBIT) has an exclusive license to develop the intellectual property and is co-owned by Utah Valley University and GJP. This ownership of PBIT and associated intellectual property does not alter policies on sharing data and materials. These financial conflicts of interest are administered by the Research Integrity and Compliance Office, Office of Research at the University of California, Davis to ensure compliance with University of California Policy. ChemCentre has an exclusive license for development and use of the Australian Patent 2011229918.
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous